Skip to main content

SITIME Corp

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

SITM$444.45-2.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except per share amounts)

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Revenue$298,671$83,567$569,670$213,375
Cost of revenue144,55338,850249,455102,270
Gross profit154,11844,717320,215111,105
Operating expenses:
Research and development62,41230,009131,26690,598
Selling, general and administrative62,08530,603147,32285,689
Acquisition related costs21,28812637,4173,560
Total operating expenses145,78560,738316,005179,847
Income (loss) from operations8,333(16,021)4,210(68,742)
Interest income1,4878,27521,34216,832
Interest expense(5,094)—(7,341)—
Other (expense) income, net(199)(157)(691)53
Income (loss) before income taxes4,527(7,903)17,520(51,857)
Income tax expense(174)(111)(228)(213)
Net income (loss)$4,353$(8,014)$17,292$(52,070)
Net income (loss) attributable to common stockholders and comprehensive income (loss)$4,353$(8,014)$17,292$(52,070)
Net income (loss) per share attributable to common stockholders, basic$0.14$(0.31)$0.63$(2.12)
Net income (loss) per share attributable to common stockholders, diluted$0.14$(0.31)$0.60$(2.12)
Weighted-average shares used to compute basic net income (loss) per share30,13426,04827,65624,551
Weighted-average shares used to compute diluted net income (loss) per share31,17026,04828,63624,551
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.